phase readout
saveNCT05397496: Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL)
view source ↗
comments(0)
5-min edit window · permanent after that